Protalix BioTherapeutics Inc (AMEX: PLX) started the day on Thursday, with a price increase of 12.36% at $2.0, before settling in for the price of $1.78 at the close. Taking a more long-term approach, PLX posted a 52-week range of $1.32-$3.10.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -25.00%. This publicly-traded company’s shares outstanding now amounts to $80.34 million, simultaneously with a float of $71.93 million. The organization now has a market capitalization sitting at $160.84 million. At the time of writing, stock’s 50-day Moving Average stood at $1.9000, while the 200-day Moving Average is $1.9200.
Protalix BioTherapeutics Inc (PLX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Protalix BioTherapeutics Inc’s current insider ownership accounts for 10.56%, in contrast to 18.09% institutional ownership. According to the most recent insider trade that took place on Dec 19 ’25, this organization’s PRESIDENT AND CEO bought 56,000 shares at the rate of 1.81, making the entire transaction reach 101,360 in total value, affecting insider ownership by 188,516. Preceding that transaction, on Nov 18 ’25, Company’s Director sold 168 for 1.87, making the whole transaction’s value amount to 314. This particular insider is now the holder of 0 in total.
Protalix BioTherapeutics Inc (AMEX: PLX) Trading Performance Indicators
Let’s observe the current performance indicators for Protalix BioTherapeutics Inc (PLX). It’s Quick Ratio in the last reported quarter now stands at 2.06. Alongside those numbers, its PE Ratio stands at $28.78, and its Beta score is -0.21. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.60.
In the same vein, PLX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.07, a figure that is expected to reach 0.04 in the next quarter, and analysts are predicting that it will be 0.20 at the market close of one year from today.
Technical Analysis of Protalix BioTherapeutics Inc (PLX)
If we take a close look at the recent performances of Protalix BioTherapeutics Inc (AMEX: PLX), its last 5-days Average volume was 1.28 million that shows progress from its year to date volume of 1.28 million. During the previous 9 days, stock’s Stochastic %D was recorded 56.34% While, its Average True Range was 70.51.
Raw Stochastic average of Protalix BioTherapeutics Inc (PLX) in the period of the previous 100 days is set at 44.96%, which indicates a major fall in contrast to 82.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1000 that was lower than 0.1100 volatility it exhibited in the past 100-days period.
